EyePoint Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
EYPT
CUSIP
30233G209
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 30233G209 since 12/18/2024, largest first.

Filer % of Class Filed
Janus Henderson Group Ltd. 13G 10.9% 9/8/2026
Event 8/31/2026
Tang Capital Management LLC 13G
9.6% 10/27/2026
Event 10/20/2026
BlackRock, Inc. 13G/A 7.7% 7/28/2026
Event 6/30/2026
Cormorant Asset Management, LP 13G/A
6.7% 11/16/2026
Event 9/30/2026
Franklin Resources, Inc. 13G/A
6.1% 1/27/2025
Event 12/31/2024
Adage Capital Management, L.P. 13G
5.7% 8/12/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
Vanguard Capital Management LLC 13G/A 4.99% 10/30/2026
Event 9/30/2026
RA Capital Management, L.P. 13G/A
4.7% 2/14/2025
Event 12/31/2024
TCG Crossover GP II, LLC 13G/A
4.3% 2/17/2026
Event 12/31/2025
Paradigm Biocapital Advisors LP 13G/A
3.8% 5/15/2026
Event 3/31/2026
Federated Hermes, Inc. 13G/A
1.6% 11/4/2026
Event 10/31/2026
Commodore Capital LP 13G/A
0% 11/16/2026
Event 9/30/2026
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 193 96.0 M $301M
2026 Q2 195 92.9 M $1.33B
2026 Q1 193 89.3 M $1.15B
2025 Q4 169 83.6 M $1.53B
2025 Q3 153 69.9 M $995M
2025 Q2 145 68.9 M $648M
2025 Q1 154 74.1 M $401M
2024 Q4 148 74.4 M $553M
2024 Q3 140 58.5 M $476M
2024 Q2 157 58.5 M $509M
2024 Q1 170 55.0 M $1.14B
2023 Q4 143 49.6 M $1.15B
2023 Q3 106 33.7 M $269M
2023 Q2 84 31.6 M $275M
2023 Q1 68 29.1 M $85.6M
2022 Q4 76 29.4 M $103M
2022 Q3 86 30.1 M $238M
2022 Q2 86 30.2 M $238M
2022 Q1 85 30.4 M $370M
2021 Q4 93 29.8 M $365M
2021 Q3 66 22.1 M $231M
2021 Q2 62 20.7 M $186M
2021 Q1 60 19.6 M $200M
2020 Q4 35 7.70 M $50.7M